ARCHIVES

Witnesses Seek 15% Boost For NCI In 1998 as First Step to 100% Raise Over 5 Years

This article is from The Cancer Letter archive.

Vol. 23 No. 18 | May 9, 1997

Download PDF Visit The Full Archive

Related Articles

Erbitux Improves Survival In Advanced Colorectal Cancer

November 30, 2007

Funding Opportunities

October 25, 2002

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

January 4, 2002

To Review Cancer Bioinformatics Grid

November 12, 2010

Cancer Program Progress Detailed

March 5, 1976